Erk1/2 and Akt kinases are involved in the protective effect of aniracetam in astrocytes subjected to simulated ischemia in vitro

European Journal of Pharmacology

Volumn 494, Issue 2-3, 2004, Pages 111-120

  Gabryel, Bozena ^a   Pudelko, Anna ^a   Malecki, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Akt; Aniracetam; Apoptosis; Astrocyte; Erk1 2; Ischemia

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANIRACETAM; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME RELEASE; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIMULATION;

ANIMALS; APOPTOSIS; ASTROCYTES; BENZIMIDAZOLES; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; FLUORESCENT DYES; L-LACTATE DEHYDROGENASE; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; NEUROPROTECTIVE AGENTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLIDINONES; RATS; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 2942707812     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.04.042     Document Type: Article

References (30)

1. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem. 72:1976;248-251
2. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidilinositol-3-OH kinase signal. Nature. 376:1995;599-602
3. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321
4. Chang L., Karin M. Mammalian MAP kinase signaling cascades. Nature. 410:2001;37-40
5. Cumin R., Bandle E.F., Gamzu E., Haefely W.E. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology. 78:1982;104-111
6. Franke T.F., Kaplan D.R., Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell. 88:1997;435-437
7. Gabryel B., Adamek M., Trzeciak H.I. Does trimetazidine exert cytoprotective activity on astrocytes subjected to hypoxia in vitro? Neurotoxicology. 22:2001;455-465
8. Gabryel B., Adamczyk J., Huzarska M., Pudelko A., Trzeciak H.I. Aniracetam attenuates apoptosis of astrocytes subjected to simulated ischemia in vitro. Neurotoxicology. 23:2002;385-395
9. +2-permeable AMPA receptors. Nature. 381:1996;793-796
10. Hatten M.E., Liem R.K.H., Shelanski M.L., Mason C.A. Astroglia in CNS injury. Glia. 4:1991;233-243
11. Hertz L., Juurlink B.H.J., Szuchet S. Cell cultures. Lajtha A. Handbook of Neurochemistry. 1985;603-661 Plenum Press, New York, NY
12. Heusch W.L., Maneckjee R. Signaling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis. 19:2001;551-556
13. Himori N., Mishima K. Amelioration by aniracetam of abnormalities as reevaluated in choice reaction performance and shuttle behavior. Pharmacol. Biochem. Behav. 47:1994;219-225
14. Jiang Z., Zuang Y., Chen X., Lam P.Y., Yang H., Xu Q., Yu A.C.H. Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem. Biophys. Res. Commun. 294:2002;726-733
15. Martin J.R., Haevely W.E. Pharmacology of aniracetam: a novel pyrrolidinone derivative with cognitive enhancing activity. Drug Investig. 5:1993;4-49
16. Mosman T. Rapid, colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63
17. Noshita N., Lewen T., Sugawara P.H., Chan P.H. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 21:2001;1442-1450
18. Otomo E., Hirai S., Terashi A., Hasegawa K., Tazaki Y., Araki G., Itoh E., Nishimura T., Furukawa T. Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: double-blind trial placebo. J. Clin. Exp. Med. 156:1991;143-187
19. Pende M., Fischer T.L., Simpson P.B., Russell J.T., Blenis J., Gallo V. Neurotransmitter- and growth factor induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 kinase pathway. J. Neurosci. 15:1997;1291-1301
20. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:1999;2435-2444
21. Shearman M.S., Hawtin S.R., Tailor V.J. The intracellular component of cellular 3-(4, 5-dimethylthazol-2-yl)-2, 5-diphenyltetrazolinum bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J. Neurochem. 65:1995;218-227
22. Shirane M., Nakamura K. Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP. Brain Res. 916:2001;211-221
23. Simmons M.L., Murphy S. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:1992;897-905
24. Sweat J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76:2001;1-10
25. Tsuzuki K., Takeuchi T., Ozawa S. Agonist-dependent and subunit-dependent potentiation of glutamate receptors by nootropic drug aniracetam. Mol. Brain Res. 16:1992;105-110
26. Vemuri G.S., McMorris F.A. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development. 122:1996;2529-2537
27. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180
28. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interlekin-1β-converting enzyme. Cell. 75:1993;641-652
29. Yujiri T., Sather S., Fanger G.R., Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914
30. Zajaczkowski W., Danysz W. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions. Pharmacol. Biochem. Behav. 56:1997;21-29